Literature DB >> 6333362

Pathogenesis and cellular immunity in experimental murine brucellosis.

C Cheers.   

Abstract

Infection of mice with Brucella abortus strain 19 provides a most useful and interesting model in which to study chronic infection with intracellular bacteria. Most strains of mice develop a chronic infection. However, certain strains are better able to handle their infection. Long term bone marrow chimeras showed this to be due to bone marrow derived cells, rather than host physiology, although whether it is due T or B lymphocytes, macrophages or polymorphs is yet to be determined. In vitro treatment of lymphocytes from infected donors showed that the subpopulations transferring protection to naive mice was Thy 1+ 2+ Ia-. i.e. the same T cell which induces cell mediated immunity to Listeria. In vivo injection of an optimal regime of anti Ly1 monoclonal antibody exacerbated infection and removed the population of cells transferring immunity. Sub-optimal amounts of anti-Ly-1 abrogated IgG Brucella agglutinating antibody without affecting bacterial numbers, thus confirming the T dependence of IgG antibody and suggesting that it is not important in recovery from infection. Marked splenomegaly occurred about 3 weeks after infection of the mice. It was transferred by T lymphocytes and involved marked influx of macrophages, increased haemopoiesis, fibrin deposition and fluid in the spleen. Although the macrophages were immunosuppressive in vitro they did not appear to account for chronicity of infection. In seeking to account for this chronicity we have compared a number of aspects of the immune response in chronically infected mice and in mice which were able to control their infection. Although we have ruled out a number of possibilities, we have not yet established the basis of chronicity.

Entities:  

Mesh:

Year:  1984        PMID: 6333362

Source DB:  PubMed          Journal:  Dev Biol Stand        ISSN: 0301-5149


  19 in total

1.  Bacterial persistence and immunity in goats vaccinated with a purE deletion mutant or the parental 16M strain of Brucella melitensis.

Authors:  N F Cheville; S C Olsen; A E Jensen; M G Stevens; A M Florance; H S Houng; E S Drazek; R L Warren; T L Hadfield; D L Hoover
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  Comparative protection of mice against virulent and attenuated strains of Brucella abortus by passive transfer of immune T cells or serum.

Authors:  L N Araya; A J Winter
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

3.  TLR2 and TLR4 signaling pathways are required for recombinant Brucella abortus BCSP31-induced cytokine production, functional upregulation of mouse macrophages, and the Th1 immune response in vivo and in vitro.

Authors:  Jia-Yun Li; Yuan Liu; Xiao-Xue Gao; Xiang Gao; Hong Cai
Journal:  Cell Mol Immunol       Date:  2014-04-28       Impact factor: 11.530

4.  A B lymphocyte mitogen is a Brucella abortus virulence factor required for persistent infection.

Authors:  Juan Manuel Spera; Juan Esteban Ugalde; Juan Mucci; Diego J Comerci; Rodolfo Augusto Ugalde
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-19       Impact factor: 11.205

5.  Comparison of living and nonliving vaccines for Brucella abortus in BALB/c mice.

Authors:  J A Montaraz; A J Winter
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

6.  Protection against Brucella abortus in mice with O-polysaccharide-specific monoclonal antibodies.

Authors:  J A Montaraz; A J Winter; D M Hunter; B A Sowa; A M Wu; L G Adams
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

7.  Alteration of protective and serologic responses in BALB/c mice vaccinated with chemically modified versus nonmodified proteins of Brucella abortus 19.

Authors:  G W Pugh; L B Tabatabai
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

8.  Effect of recombinant human macrophage colony-stimulating factor 1 on immunopathology of experimental brucellosis in mice.

Authors:  A G Doyle; W J Halliday; C J Barnett; T L Dunn; D A Hume
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

9.  Brucella lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation used.

Authors:  Carlos A Velikovsky; Fernando A Goldbaum; Juliana Cassataro; Silvia Estein; Raúl A Bowden; Laura Bruno; Carlos A Fossati; Guillermo H Giambartolomei
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

10.  Variation of Brucella abortus 2308 infection in BALB/c mice induced by prior vaccination with salt-extractable periplasmic proteins from Brucella abortus 19.

Authors:  G W Pugh; L B Tabatabai
Journal:  Infect Immun       Date:  1996-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.